論文・総説 - 三浦　雅彦

分割表示 >> ／  全件表示  178 件中 1 - 178 件目

  1. Arisa Oki, Shin Nakamura, Junichiro Sakamoto, Hiroshi Watanabe, Masahiko Miura. Can MRI radiomics predict neck metastasis at initial diagnosis in patients with squamous cell carcinoma of the tongue? Oral Radiology. 2025.07; 41 (3): 388-395.

  2. Atsushi Kaida, Yuriko Igarashi, Hitomi Nojima, Mio Nakayama, Ryuhei Okada, Ryosuke Takahashi, Hisataka Kobayashi, Masahiko Miura. Uncovering cell cycle-dependent effects on cell survival in near-infrared photoimmunotherapy. Experimental Cell Research. 2025.05; 448 (2): 114570. ( PubMed, DOI )

  3. Takuya Nagano, Yusuke Matsuya, Atsushi Kaida, Hitomi Nojima, Takuya Furuta, Kaoru Sato, Ryoichi Yoshimura, Masahiko Miura. In vitro and in silico study of biological effects on cancer cells in the presence of metallic materials during radiotherapy. J Radiat Res. 2024.09; 65 (5): 628-639. ( PubMed, DOI )

  4. Atsushi Kaida, Hitomi Nojima, Masahiko Miura. Estimating Impacts of p16 Status on Tumor Radiosensitivity in Head and Neck Cancer using Predictive Models. Radiat Res. 2024.09; 202 (3): 605-609. ( PubMed, DOI )

  5. Hitomi Nojima, Atsushi Kaida, Yusuke Matsuya, Motohiro Uo, Ryo-Ichi Yoshimura, Lior Arazi, Masahiko Miura. DNA damage response in a 2D-culture model by diffusing alpha-emitters radiation therapy (Alpha-DaRT). Sci Rep. 2024.05; 14 (1): 11468. ( PubMed, DOI )

  6. Supasith Yomtako, Hiroshi Watanabe, Ami Kuribayashi, Junichiro Sakamoto, Masahiko Miura. Differentiation of radicular cysts and radicular granulomas via texture analysis of multi-slice computed tomography images. Dentomaxillofac Radiol. 2024.04; 53 (5): 281-288. ( PubMed, DOI )

  7. Hirofumi Tomioka, Naoto Nishii, Yu Oikawa, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Kou Kayamori, Atsushi Kaida, Masahiko Miura, Hiroyuki Harada. Clinicopathological analysis of 134 patients with squamous cell carcinoma of the mandibular gingiva. Heliyon. 2024.01; 10 (1): e23120. ( PubMed, DOI )

  8. Wamasing N, Nakamura S, Watanabe H, Kuribayashi A, Miura M. Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer. Nucl Med Commun. 2023.12; 44 (12): 1168-1175. ( PubMed, DOI )

  9. Takuma Kugimoto, Naoto Nishii, Yu Oikawa, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Junichiro Sakamoto, Joe Iwanaga, R Shane Tubbs, Tohru Ikeda, Masahiko Miura, Hiroyuki Harada. Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion pattern. Front Oncol. 2023.10; 13 1168376. ( PubMed, DOI )

  10. Nakamura S, Watanabe H, Kurabayashi T, Miura M. Risk factors for posttreatment mastoid cellulitis in patients with oral malignancy Oral Radiology. 2023.07; 39 (3): 528-535. ( DOI )

  11. Ito K, Tokura S, Takazawa I, Yoshida N, Nakanishi T, Akiyama K, Onuma Y, Adachi T, Harada H, Nojima H, Miura M, Yoshimura R, Kabasawa Y. Clinical investigation of use of Episil® oral solution in oral mucositis during radiotherapy for head and neck cancer. Heliyon. 2023.06; 9 (6): e15869. ( PubMed, DOI )

  12. Yoshikazu Nomura, Hiroshi Watanabe, Hiroshi Tomisato, Sakurako Kawashima, Masahiko Miura. Gumbel distribution-based technique enables quantitative comparison between streak metal artifacts of multidetector row CT and cone-beam CT: a phantom study. Phys Eng Sci Med. 2023.06; 46 (2): 801-812. ( PubMed, DOI )

  13. Hitomi Nojima, Atsushi Kaida, Hiroyuki Harada, Masako Akiyama, Masahiko Miura. Effect of Ablative Dose Irradiation on Redistribution and Radioresponse in a Mouse Xenograft Model. Radiat Res. 2022.12; 198 (6): 632-638. ( PubMed, DOI )

  14. Kohki Tohyama, Atsushi Kaida, Masahiko Miura. Determination of Clonogenic Radiosensitivity of HeLa Cells in Early and Late G1 Phases Anticancer Res. 2022.11; 42 (11): 5407-5413. ( PubMed, DOI )

  15. Hitomi Nojima, Atsushi Kaida, Takeshi Kuroshima, Ryo-Ichi Yoshimura, Masahiko Miura. Retrograde Migration of an Au-198 Grain to the Submandibular Gland Post Brachytherapy Treatment of Floor of Mouth Cancer. Cureus. 2022.11; 14 (11): e31904. ( PubMed, DOI )

  16. Kazuki Takahashi, Katarzyna A Podyma-Inoue, Maki Saito, Shintaro Sakakitani, Akinari Sugauchi, Keita Iida, Sadahiro Iwabuchi, Daizo Koinuma, Kyoko Kurioka, Toru Konishi, Susumu Tanaka, Atsushi Kaida, Masahiko Miura, Shinichi Hashimoto, Mariko Okada, Toshihiro Uchihashi, Kohei Miyazono, Tetsuro Watabe. TGF-β generates a population of cancer cells residing in G1 phase with high motility and metastatic potential via KRTAP2-3. Cell Rep. 2022.09; 40 (13): 111411. ( PubMed, DOI )

  17. Esther Feng Ying Ng, Atsushi Kaida, Hitomi Nojima, Masahiko Miura. Roles of IGFBP-3 in cell migration and growth in an endophytic tongue squamous cell carcinoma cell line. Sci Rep. 2022.07; 12 (1): 11503. ( PubMed, DOI )

  18. Rika Noji, Kohki Tohyama, Takuma Kugimoto, Takeshi Kuroshima, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Akihisa Tasaki, Kazuchika Ohno, Yosuke Ariizumi, Iichiroh Onishi, Mitsukuni Suenaga, Takehiko Mori, Ryuichi Okamoto, Ryoichi Yoshimura, Masahiko Miura, Takahiro Asakage, Satoshi Miyake, Sadakatsu Ikeda, Hiroyuki Harada, Yoshihito Kano. Comprehensive Genomic Profiling Reveals Clinical Associations in Response to Immune Therapy in Head and Neck Cancer. Cancers (Basel). 2022.07; 14 (14): ( PubMed, DOI )

  19. Shigehiro Abe, Atsushi Kaida, Kazunori Kanemaru, Keiichiro Nakazato, Naoko Yokomizo, Yutaka Kobayashi, Masahiko Miura, Toshio Miki, Chiaki Hidai, Hisataka Kitano, Tetsuya Yoda. Differences in the stemness characteristics and molecular markers of distinct human oral tissue neural crest-derived multilineage cells. Cell Prolif. 2022.06; e13286. ( PubMed, DOI )

  20. Ryo-Ichi Yoshimura, Kazuma Toda, Hiroshi Watanabe, Atsushi Kaida, Hiroyuki Harada, Takahiro Asakage, Masahiko Miura. Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer. Anticancer Res. 2021.12; 41 (12): 6259-6266. ( PubMed, DOI )

  21. Takeshi Kuroshima, Yusuke Onozato, Yu Oikawa, Toshimitsu Ohsako, Takuma Kugimoto, Hideaki Hirai, Hirofumi Tomioka, Yasuyuki Michi, Masahiko Miura, Ryoichi Yoshimura, Hiroyuki Harada. Prognostic impact of lingual lymph node metastasis in patients with squamous cell carcinoma of the tongue: a retrospective study. Sci Rep. 2021.10; 11 (1): 20535. ( PubMed, DOI )

  22. Yoshihide Ota, Tadahide Noguchi, Masahiko Miura et al.. General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis. Int J Clin Oncol. 2021.04; 26 (4): 623-635. ( PubMed, DOI )

  23. Kohei Okuyama, Keiji Suzuki, Tomofumi Naruse, Hiroki Tsuchihashi, Souichi Yanamoto, Atsushi Kaida, Masahiko Miura, Masahiro Umeda, Shunichi Yamashita. Prolonged cetuximab treatment promotes p27 Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma. Sci Rep. 2021.03; 11 (1): 5259. ( PubMed, DOI )

  24. Hiroaki Shimono, Atsushi Kaida, Hisao Homma, Hitomi Nojima, Yusuke Onozato, Hiroyuki Harada, Masahiko Miura. Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency. Sci Rep. 2020.11; 10 (1): 20873. ( PubMed, DOI )

  25. Hideaki Hirai, Toshimitsu Ohsako, Takuma Kugimoto, Hirofumi Tomioka, Yasuyuki Michi, Kou Kayamori, Tetsuya Yoda, Masahiko Miura, Ryoichi Yoshimura, Hiroyuki Harada. Comparison of 50- and 66-Gy total irradiation doses for postoperative cervical treatment of patients with oral squamous cell carcinoma Oral Oncol. 2020.08; 107 104708. ( PubMed, DOI )

  26. Nojima Hitomi, Homma Hisao, Onozato Yusuke, Kaida Atsushi, Harada Hiroyuki, Miura Masahiko. Differential properties of mitosis-associated events following CHK1 and WEE1 inhibitor treatments in human tongue carcinoma cells EXPERIMENTAL CELL RESEARCH. 2020.01; 386 (2): 111720. ( PubMed, DOI )

  27. Hisao Homma, Hitomi Nojima, Atsusi Kaida, Masahiko Miura. Induction of endomitosis-like event in HeLa cells following CHK1 inhibitor treatment Biochem Biophys Res Commun. 2019.12; 520 (2): 492-497. ( PubMed )

  28. Goto T, Homma H, Kaida A, Miura M. WEE1 inhibition enhances sensitivity to hypoxia/reoxygenation in HeLa cells. J Radiat Res. 2019.09; 60 (5): 714-718. ( PubMed, DOI )

  29. Yoichi Takakusagi, Sarwat Naz, Kaori Takakusagi, Masahiro Ishima, Hiroshi Murata, Keisuke Ohta, Masahiko Miura, Fumio Sugawara, Kengo Sakaguchi, Shun Kishimoto, Jeeva P Munasinghe, James B Mitchell, Murali C Krishna. A Multimodal Molecular Imaging Study Evaluates Pharmacological Alteration of the Tumor Microenvironment to Improve Radiation Response. Cancer Res.. 2018.12; 78 (24): 6828-6837. ( PubMed, DOI )

  30. Nisha Gowri Manila, Atsushi Kaida, Ken-Ichi Nakahama, Masahiko Miura. Insulin-like growth factor I receptor regulates the radiation-induced G2/M checkpoint in HeLa cells. Biochem. Biophys. Res. Commun.. 2018.08; 503 (4): 2977-2987. ( PubMed, DOI )

  31. Sirimanas Jiaranuchart, Atsushi Kaida, Yusuke Onozato, Hiroyuki Harada, Masahiko Miura. DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4. Arch. Oral Biol.. 2018.06; 90 1-8. ( PubMed, DOI )

  32. Tatsushi Ruike, Yoshihiro Kanai, Kazuki Iwabata, Yuki Matsumoto, Hiroshi Murata, Masahiro Ishima, Keisuke Ohta, Masahiko Oshige, Shinji Katsura, Koji Kuramochi, Shinji Kamisuki, Hiroeki Sahara, Masahiko Miura, Fumio Sugawara, Kengo Sakaguchi. Distribuiton and metabolism of 14C Sulfoquinovosylacylpropanediol (14C-SQAP) after a single intravenous administration in tumor-bearing mice. Xenobiotica. 2018.03; 1-45. ( PubMed, DOI )

  33. Sato M, Saito Y, Takayama T, Omata T, Watanabe H, Yoshimura R, Miura M.. Remote radioactive seed-loading device for permanent brachytherapy of oral cancer with Au-198 grains. Robomech Journal. 2017.09; 4 23.

  34. Atsushi Kaida, Hiroshi Watanabe, Kazuma Toda, Keiko Yuasa-Nakagawa, Ryoichi Yoshimura, Masahiko Miura. Effects of dose rate on early and late complications in low dose rate brachytherapy for mobile tongue carcinoma using Ir-192 sources. Oral Radiol. 2017.09; 33 (3): 187-192. ( DOI )

  35. Atsushi Oba, Shu Shimada, Yoshimitsu Akiyama, Taketo Nishikawaji, Kaoru Mogushi, Hiromitsu Ito, Satoshi Matsumura, Arihiro Aihara, Yusuke Mitsunori, Daisuke Ban, Takanori Ochiai, Atsushi Kudo, Hiroshi Asahara, Atsushi Kaida, Masahiko Miura, Minoru Tanabe, Shinji Tanaka. ARID2 modulates DNA damage response in human hepatocellular carcinoma cells. J. Hepatol.. 2017.05; 66 (5): 942-951. ( PubMed, DOI )

  36. Yusuke Onozato, Atsushi Kaida, Hiroyuki Harada, Masahiko Miura. Radiosensitivity of quiescent and proliferating cells grown as multicellular tumor spheroids. Cancer Sci. 2017.04; 108 (4): 704-712. ( PubMed, DOI )

  37. Manila Nisha Gowri, Kaida Atsushi, Miura Masahiko. Roles of insulin-like growth factor I receptor(IGF-IR) in HeLa cells following irradiation) J. Stomatol. Soc. 2017.03; 84 (1): 51. ( 医中誌 )

  38. Y Ozaki, H Watanabe, A Kaida, M Miura, K Nakagawa, K Toda, R Yoshimura, Y Sumi, T Kurabayashi. Estimation of whole-body radiation exposure from brachytherapy for oral cancer using a Monte Carlo simulation. J. Radiat. Res.. 2017.02; 24 1-6. ( PubMed, DOI )

  39. Nisha Gowri Manila, Atsushi Kaida, Masahiko Miura. Kinetic analysis of radiation-induced cell-cycle alterations in HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci). Radiat Environ Med. 2016.08; 5 (2): 16-21.

  40. Taito Asahina, Atsushi Kaida, Tatsuaki Goto, Ryo-Ichi Yoshimura, Keisuke Sasai, Masahiko Miura. Temporo-spatial cell-cycle kinetics in HeLa cells irradiated by Ir-192 high dose-rate remote afterloading system (HDR-RALS). Radiat Oncol. 2016.07; 11 99. ( PubMed, DOI )

  41. Tatsuaki Goto, Atsushi Kaida, Masahiko Miura. Visualizing cell-cycle kinetics after hypoxia/reoxygenation in HeLa cells expressing fluorescent ubiquitination-based cell cycle indicator (Fucci). Exp. Cell Res.. 2015.12; 339 (2): 389-396. ( PubMed, DOI )

  42. Kohei Okuyama, Atsushi Kaida, Yoshiki Hayashi, Yoshio Hayashi, Kiyoshi Harada, Masahiko Miura. KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase. PLoS ONE. 2015.12; 10 (12): e0145995. ( PubMed, DOI )

  43. Jesus Izaguirre-Carbonell, Hirofumi Kawakubo, Hiroshi Murata, Atsushi Tanabe, Toshifumi Takeuchi, Tomoe Kusayanagi, Senko Tsukuda, Takeshi Hirakawa, Kazuki Iwabata, Yoshihiro Kanai, Keisuke Ohta, Masahiko Miura, Kengo Sakaguchi, Sachihiro Matsunaga, Hiroeki Sahara, Shinji Kamisuki, Fumio Sugawara. Novel anticancer agent, SQAP, binds to focal adhesion kinase and modulates its activity. Sci Rep. 2015.10; 5 15136. ( PubMed, DOI )

  44. Atsushi Kaida, Masahiko Miura. Unusual prolongation of radiation-induced G2 arrest in tumor xenografts derived from HeLa cells. Cancer Sci. 2015.10; 106 (10): 1370-1376. ( PubMed, DOI )

  45. Yugo Sawada, Kazuya Omoto, Naoki Kohei, Kengo Sakaguchi, Masahiko Miura, Kazunari Tanabe. Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer. Int. J. Urol.. 2015.06; 22 (6): 590-595. ( PubMed, DOI )

  46. Eri Tsuchida, Atsushi Kaida, Endrawan Pratama, Masa-Aki Ikeda, Keiji Suzuki, Kiyoshi Harada, Masahiko Miura. Effect of X-Irradiation at Different Stages in the Cell Cycle on Individual Cell-Based Kinetics in an Asynchronous Cell Population. PLoS ONE. 2015.06; 10 (6): e0128090. ( PubMed, DOI )

  47. Chisato Yamada, Atsushi Kaida, Kohei Okuyama, Kiyoshi Harada, Masahiko Miura. Effects of Chk1 inhibitor or paclitaxel on cisplatin-induced cell-cycle kinetics and survival in parental and cisplatin-resistant HeLa cells expressing fluorescent ubiquitination based cell cycle indicator (Fucci). Integr Cancer Sci Therap. 2015.02; 2 87-92.

  48. Lian Xue, Yoshiya Furusawa, Ryuichi Okayasu, Masahiko Miura, Xing Cui, Cuihua Liu, Ryoichi Hirayama, Yoshitaka Matsumoto, Hirohiko Yajima, Dong Yu. The complexity of DNA double strand break is a crucial factor for activating ATR signaling pathway for G2/M checkpoint regulation regardless of ATM function. DNA Repair (Amst.). 2015.01; 25 72-83. ( PubMed, DOI )

  49. Eslami A, Miyagushi K, Mogushi K, Watanabe H, Okada N, Shibuya H, Mizushima H, Miura M, Tanaka H.. PARVB overexertion increased cell migration capability and defines high risk for endophytic growth and metastasis in tongue squamous cell carcinoma. British Journal of Cancer. 2015.01; 112 (2): 338-344. ( PubMed, DOI )

  50. Yoshiki Hayashi, Haruka Takeno, Takumi Chinen, Kyohei Muguruma, Kohei Okuyama, Akihiro Taguchi, Kentaro Takayama, Fumika Yakushiji, Masahiko Miura, Takeo Usui, Yoshio Hayashi. Development of a new benzophenone-diketopiperazine-type potent antimicrotubule agent possessing a 2-pyridine structure. ACS Med Chem Lett. 2014.10; 5 (10): 1094-1098. ( PubMed, DOI )

  51. Kamrun Nahar, Tatsuaki Goto, Atsushi Kaida, Shifumi Deguchi, Masahiko Miura. Effects of Chk1 inhibition on the temporal duration of radiation-induced G2 arrest in HeLa cells. J. Radiat. Res.. 2014.09; 55 (5): 1021-1027. ( PubMed, DOI )

  52. Atsushi Kaida, Masahiko Miura. Visualizing the effect of tumor microenvironments on radiation-induced cell kinetics in multicellular spheroids consisting of HeLa cells. Biochem. Biophys. Res. Commun.. 2013.10; 439 (4): 453-458. ( PubMed, DOI )

  53. Keiko Yuasa-Nakagawa, Hitoshi Shibuya, Ryoichi Yoshimura, Masahiko Miura, Hiroshi Watanabe, Seiji Kishimoto, Ken Omura. Cervical lymph node metastasis from early-stage squamous cell carcinoma of the oral tongue. Acta Otolaryngol.. 2013.05; 133 (5): 544-551. ( PubMed, DOI )

  54. Asumi Honda-Uezono, Atsushi Kaida, Yasuyuki Michi, Kiyoshi Harada, Yoshiki Hayashi, Yoshio Hayashi, Masahiko Miura. Unusual expression of red fluorescence at M phase induced by anti-microtubule agents in HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci). Biochem. Biophys. Res. Commun.. 2012.11; 428 (2): 224-229. ( PubMed, DOI )

  55. Shigehiro Abe, Keiichi Hamada, Masahiko Miura, Satoshi Yamaguchi. Neural crest stem cell property of apical pulp cells derived from human developing tooth. Cell Biol. Int.. 2012.10; 36 (10): 927-936. ( PubMed, DOI )

  56. Yoshimura RI, Shibuya H, Hayashi K, Nakagawa K, Toda K, Watanabe H, Kaida A, Miura M. Repeat Brachytherapy for Patients with Residual or Recurrent Tumors of Oral Cavity. Int J Radiat Oncol Biol Phys. 2012.07; 83 (4): 1198-1204. ( PubMed, DOI )

  57. Yuka Miyano, Senko Tsukuda, Ippei Sakimoto, Ryo Takeuchi, Satomi Shimura, Noriyuki Takahashi, Tomoe Kusayanagi, Yoichi Takakusagi, Mami Okado, Yuki Matsumoto, Kaori Takakusagi, Toshifumi Takeuchi, Shinji Kamisuki, Atsuo Nakazaki, Keisuke Ohta, Masahiko Miura, Kouji Kuramochi, Yoshiyuki Mizushina, Susumu Kobayashi, Fumio Sugawara, Kengo Sakaguchi. Exploration of the binding proteins of perfluorooctane sulfonate by a T7 phage display screen. Bioorg. Med. Chem.. 2012.07; 20 (13): 3985-3990. ( PubMed, DOI )

  58. Atsushi Kaida, Masahiko Miura. Differential dependence on oxygen tension during the maturation process between monomeric Kusabira Orange 2 and monomeric Azami Green expressed in HeLa cells. Biochem. Biophys. Res. Commun.. 2012.05; 421 (4): 855-859. ( PubMed, DOI )

  59. Kaida A, Miura M. Visualizing the effect of hypoxia on fluorescence kinetics in living HeLa cells using the fluorescent ubiquitination-based cell cycle indicator (Fucci). Exp Cell Res. 2012.02; 318 (3): 288-297. ( PubMed, DOI )

  60. Yoshimura R, Shibuya H, Hayashi K, Toda K, Watanabe H, Miura M. Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients. Br J Radiol. 2011.10; 84 (1006): 930-938. ( PubMed, DOI )

  61. Nakayama M, Kaida A, Deguchi S, Sakaguchi K, Miura M. Radiosensitivity of early and late M-phase HeLa cells isolated by a combination of fluorescent ubiquitination-based cell cycle indicator (Fucci) and mitotic shake-off. Radiat Res. 2011.09; 176 (3): 407-411. ( PubMed )

  62. Kaida A, Sawai N, Sakaguchi K, Miura M. Fluorescence kinetics in HeLa cells after treatment with cell cycle arrest inducers visualized with Fucci (fluorescent ubiquitination-based cell cycle indicator). Cell Biol Int. 2011.04; 35 (4): 359-363. ( PubMed, DOI )

  63. Abe S, Hamada K, Yamaguchi S, Amagasa T, Miura M. Characterization of the radioresponse of human apical papilla-derived cells. Stem Cell Res Ther. 2011; 2 (1): 2. ( PubMed, DOI )

  64. Ohta K, Murata H, Mori Y, Ishima M, Sugawara F, Sakaguchi K, Miura M. Remodeling of the tumor microenvironment by combined treatment with a novel radiosensitizer, {alpha}-sulfoquinovosylmonoacylglycerol ({alpha}-SQMG) and X-irradiation. Anticancer Res. 2010.11; 30 (11): 4397-4404. ( PubMed )

  65. Ishikawa M, Ogihara Y, Miura M. Visualization of radiation-induced cell cycle-associated events in tumor cells expressing the fusion protein of Azami Green and the destruction box of human Geminin. Biochem Biophys Res Commun. 2009.11; 389 (3): 426-430. ( PubMed, DOI )

  66. Sermsathanasawadi N, Ishii H, Igarashi K, Miura M, Yoshida M, Inoue Y, Iwai T. Enhanced adhesion of early endothelial progenitor cells to radiation-induced senescence-like vascular endothelial cells in vitro. J Radiat Res. 2009.09; 50 (5): 469-475. ( PubMed )

  67. Miura M. Radiotherapy for oral tumors and translational research J Stomatol Soc. 2009.03; 76 (1): 8-15. ( PubMed )

  68. Ryo-ichi Yoshimura, Hitoshi Shibuya, Masahiko Miura, Hiroshi Watanabe, Fumio Ayukawa, Keiji Hayashi, Kazuma Toda. Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2009.03; 73 (3): 772-778. ( PubMed, DOI )

  69. Igarashi K, Miura M. Inhibition of a radiation-induced senescence-like phenotype: a possible mechanism for potentially lethal damage repair in vascular endothelial cells. Radiat Res. 2008.10; 170 (4): 534-539. ( PubMed )

  70. Watanabe H, Mogushi K, Miura M, Yoshimura R, Kurabayashi T, Shibuya H, Tanaka H, Noda S, Iwakawa M, Imai T. Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma. Radiother Oncol. 2008.05; 87 (2): 237-242. ( PubMed, DOI )

  71. Yoko Mori, Hiroeki Sahara, Kayo Matsumoto, Nobuaki Takahashi, Takayuki Yamazaki, Keisuke Ohta, Satoko Aoki, Masahiko Miura, Fumio Sugawara, Kengo Sakaguchi, Noriyuki Sato. Downregulation of Tie2 gene by a novel antitumor sulfolipid, 3'-sulfoquinovosyl-1'-monoacylglycerol, targeting angiogenesis. Cancer Sci. 2008.05; 99 (5): 1063-1070. ( PubMed, DOI )

  72. Kaneko H, Yu D, Miura M. Overexpression of IGF-I receptor in HeLa cells enhances in vivo radioresponse. Biochem Biophys Res Commun. 2007.11; 363 (4): 937-941. ( PubMed, DOI )

  73. Igarashi K, Sakimoto I, Kataoka K, Ohta K, Miura M. Radiation-induced senescence-like phenotype in proliferating and plateau-phase vascular endothelial cells. Exp Cell Res. 2007.09; 313 (15): 3326-3336. ( PubMed, DOI )

  74. Ayukawa F, Shibuya H, Yoshimura R, Watanabe H, Miura M. Curative brachytherapy for recurrent/residual tongue cancer. Strahlenther Onkol. 2007.03; 183 (3): 133-137. ( PubMed, DOI )

  75. M Kishino, H Shibuya, R Yoshimura, M Miura, H Watanabe. A retrospective analysis of the use of brachytherapy in relation to early stage squamous cell carcinoma of the oropharynx and its relationship to second primary respiratory and upper digestive tract cancers. Br J Radiol. 2007.02; 80 (950): 121-125. ( PubMed, DOI )

  76. Masahiko Miura, Ippei Sakimoto, Keisuke Ohta, Fumio Sugawara, Kengo Sakaguchi. Sulfoglycolipids as candidate antiangiogenic radiosensitizers. Anticancer Drugs. 2007.01; 18 (1): 1-5. ( PubMed, DOI )

  77. Sayako Oota, Hitoshi Shibuya, Ryo-ichi Yoshimura, Hiroshi Watanabe, Masahiko Miura. Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL. Radiat Oncol. 2006.07; 1 21. ( PubMed, DOI )

  78. Sakimoto I, Ohta K, Yamazaki T, Ohtani S, Sahara H, Sugawara F, Sakaguchi K, Miura M. Alpha-sulfoquinovosylmonoacylglycerol is a novel potent radiosensitizer targeting tumor angiogenesis. Cancer Res. 2006.02; 66 (4): 2287-2295. ( PubMed, DOI )

  79. Watanabe H, Murata Y, Miura M, Hasegawa M, Kawamoto T, Shibuya H. In-vivo visualization of radiation-induced apoptosis using (125)I-annexin V. Nucl Med Commun. 2006.01; 27 (1): 81-89. ( PubMed )

  80. Satoko Aoki, Keisuke Ohta, Kenjiro Matsumoto, Hideki Sakai, Masahiko Abe, Masahiko Miura, Fumio Sugawara, Kengo Sakaguchi. An emulsion of sulfoquinovosylacylglycerol with long-chain alkanes increases its permeability to tumor cells. J Membr Biol. 2006; 213 (1): 11-18. ( PubMed, DOI )

  81. Kaneko H, Igarashi K, Kataoka K, Miura M. Heat shock induces phosphorylation of histone H2AX in mammalian cells. Biochem Biophys Res Commun. 2005.03; 328 (4): 1101-1106. ( PubMed, DOI )

  82. Ihara N, Shibuya H, Yoshimura R, Oota S, Miura M, Watanabe H. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue. Acta Oncol. 2005; 44 (7): 709-716. ( PubMed, DOI )

  83. Kuribayashi A, Kataoka K, Kurabayashi T, Miura M. Evidence that basal activity, but not transactivation, of the epidermal growth factor receptor tyrosine kinase is required for insulin-like growth factor I-induced activation of extracellular signal-regulated kinase in oral carcinoma cells. Endocrinology. 2004.11; 145 (11): 4976-4984. ( PubMed, DOI )

  84. Hoshina M, Shibuya H, Kubo HD, Miura M, Ohashi I, Yoshimura R, Oota S. Determination of the depth of 50% of maximum ionization, I50, for electron beams by the divided difference method. Med Phys. 2004.07; 31 (7): 2068-2074. ( PubMed )

  85. Watanabe H, Kurabayashi T, Miura M. Inhibition of the extracellular signal-regulated kinase (ERK) pathway and the induction of radioresistance in rat 3Y1 cells. Int J Radiat Biol. 2004.06; 80 (6): 451-457. ( PubMed, DOI )

  86. Kataoka K, Yu D, Miura M. Activation of the phosphatidylinositol-3' kinase pathway and DNA synthesis by a mutant insulin-like growth factor I receptor lacking the NPXY motif. J Endocrinol. 2004.04; 181 (1): 139-146. ( PubMed )

  87. Kataoka K, Miura M. Insulin-like growth factor I receptor does not contribute to heat shock-induced Activation of Akt and extracellular signal-regulated kinase (ERK) in mouse embryo fibroblasts. J Radiat Res. 2004.03; 45 (1): 141-144. ( PubMed )

  88. Yu D, Shibuya H, Miura M. Roles of the insulin-like growth factor I receptor C-terminus in cellular radioresistance. Biochem Biophys Res Commun. 2003.11; 311 (1): 174-178. ( PubMed )

  89. Nakagawa T, Shibuya H, Yoshimura R, Miura M, Okada N, Kishimoto S, Amagasa M, Omura K. Neck node metastasis after successful brachytherapy for early stage tongue carcinoma. Radiother Oncol. 2003.08; 68 (2): 129-135. ( PubMed )

  90. Yu D, Watanabe H, Shibuya H, Miura M. Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor. J Biol Chem. 2003.02; 278 (9): 6702-6709. ( PubMed, DOI )

  91. Dong Y, Watanabe H, Shibuya H, Miura M. The phosphatidylinositol-3 kinase pathway is not essential for insulin-like growth factor I receptor-mediated clonogenic radioresistance. J Radiat Res. 2002.09; 43 (3): 325-329. ( PubMed )

  92. Imoto I, Tsuda H, Hirasawa A, Miura M, Sakamoto M, Hirohashi S, Inazawa J. Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy. Cancer Res. 2002.09; 62 (17): 4860-4866. ( PubMed )

  93. Miura M. [Relationship between apoptotic activity and radiosensitivity in solid tumors: does apoptosis always bring good clinical results?]. Nippon Acta Radiologica. 2002.09; 62 (10): 545-548. ( PubMed )

  94. Watanabe H, Yu D, Sasaki T, Shibuya H, Hosoi Y, Asada M, Komatsu K, Miura M. Insulin-like growth factor I receptor is expressed at normal levels in Nijmegen breakage syndrome cells. Biochem Biophys Res Commun. 2002.08; 296 (1): 62-66. ( PubMed )

  95. Yoshimura R, Shibuya H, Ogura I, Miura M, Amagasa T, Enomoto S, Kishimoto S. Trimodal combination therapy for maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys. 2002.07; 53 (3): 656-663. ( PubMed )

  96. Yamamoto E, Shibuya H, Yoshimura R, Miura M. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer. 2002.04; 94 (7): 2007-2014. ( PubMed )

  97. Tezuka M, Watanabe H, Nakamura S, Yu D, Aung W, Sasaki T, Shibuya H, Miura M. Antiapoptotic activity is dispensable for insulin-like growth factor I receptor-mediated clonogenic radioresistance after gamma-irradiation. Clin Cancer Res. 2001.10; 7 (10): 3206-3214. ( PubMed )

  98. M Miura, H Watanabe, T Sasaki, K Tatsumi, M Muto. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Exp Cell Res. 2001.02; 263 (2): 202-208. ( PubMed, DOI )

  99. Aoki A, Miura M, Akiyama F, Nakagawa N, Tanaka J, Oda S, Watanabe H, Ishikawa I. In vitro evaluation of Er:YAG laser scaling of subgingival calculus in comparison with ultrasonic scaling. J Periodontal Res. 2000.10; 35 (5): 266-277. ( PubMed )

  100. Miura M, Watanabe H, Okochi K, Sasaki T, Shibuya H. Biological response to ionizing radiation in mouse embryo fibroblasts with a targeted disruption of the DNA polymerase beta gene. Radiat Res. 2000.06; 153 (6): 773-780. ( PubMed )

  101. Yoshimura R, Shibuya H, Hoshina M, Akaike H, Takeda M, Fukuda H, Hoshi A, Miura M. Successful interstitial treatment for bilateral tongue cancer. Br J Radiol. 1999.08; 72 (860): 812-814. ( PubMed )

  102. Watanabe H, Miura M, Sasaki T. Differential effects of the insulin-like growth factor I receptor on radiosensitivity and spontaneous necrosis formation of human glioblastoma cells grown in multicellular spheroids. Exp Cell Res. 1999.07; 250 (1): 99-111. ( PubMed, DOI )

  103. Masahiko MIURA. Detection of chromatin-bound PCNA in mammalian cells and its use to study DNA excision repair. J Radiat Res. 1999.03; 40 (1): 1-12. ( PubMed )

  104. Miura M, Sasaki T. Detection of chromatin-bound PCNA in cultured cells following exposure to DNA-damaging agents. Methods Mol Biol. 1999; 113 577-582. ( PubMed, DOI )

  105. Miura M, Takeda M, Sasaki T, Inoue T, Nakayama T, Fukuda H, Hoshi A, Hoshina M, Shibuya H. Factors affecting mandibular complications in low dose rate brachytherapy for oral tongue carcinoma with special reference to spacer. Int J Radiat Oncol Biol Phys. 1998.07; 41 (4): 763-770. ( PubMed )

  106. Miura M, Baserga R. The tyrosine residue at 1250 of the insulin-like growth factor I receptor is required for ligand-mediated internalization. Biochem Biophys Res Commun. 1997.10; 239 (1): 182-185. ( PubMed, DOI )

  107. Nakamura S, Watanabe H, Miura M, Sasaki T. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts. Exp Cell Res. 1997.08; 235 (1): 287-294. ( PubMed, DOI )

  108. Y Wang, N Cheong, M Miura, G Iliakis. Overexpression of insulin-like growth factor (IGF)-I receptor enhances inhibition of DNA replication in mouse cells exposed to x-rays. Radiat Environ Biophys. 1997.06; 36 (2): 117-123. ( PubMed, DOI )

  109. Miura M, Sasaki T. Effect of XPA gene mutations on UV-induced immunostaining of PCNA in fibroblasts from xeroderma pigmentosum group A patients. Mutat Res. 1996.09; 364 (1): 51-56. ( PubMed )

  110. Miura M, Nakamura S, Sasaki T, Takasaki Y, Shiomi T, Yamaizumi M. Roles of XPG and XPF/ERCC1 endonucleases in UV-induced immunostaining of PCNA in fibroblasts. Exp Cell Res. 1996.07; 226 (1): 126-132. ( PubMed, DOI )

  111. Hongo A, D'Ambrosio C, Miura M, Morrione A, Baserga R. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene. 1996.03; 12 (6): 1231-1238. ( PubMed )

  112. Miura M, Sasaki T, Takasaki Y. Characterization of X-ray-induced immunostaining of proliferating cell nuclear antigen in human diploid fibroblasts. Radiat Res. 1996.01; 145 (1): 75-80. ( PubMed )

  113. Miura M, Surmacz E, Burgaud JL, Baserga R. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem. 1995.09; 270 (38): 22639-22644. ( PubMed )

  114. Miura M, Li S, Baserga R. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells. Cancer Res. 1995.02; 55 (3): 663-667. ( PubMed )

  115. Li S, Ferber A, Miura M, Baserga R. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J Biol Chem. 1994.12; 269 (51): 32558-32564. ( PubMed )

  116. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol. 1994.07; 14 (7): 4588-4595. ( PubMed )

  117. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R, Efstratiadis A, Baserga R. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol. 1994.06; 14 (6): 3604-3612. ( PubMed )

  118. Miura M, Li SW, Dumenil G, Baserga R. Platelet-derived growth factor-induced expression of messenger RNA for the proliferating cell nuclear antigen requires a functional receptor for the insulin-like growth factor I. Cancer Res. 1994.05; 54 (9): 2472-2477. ( PubMed )

  119. Ambrose D, Resnicoff M, Coppola D, Sell C, Miura M, Jameson S, Baserga R, Rubin R. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J Cell Physiol. 1994.04; 159 (1): 92-100. ( PubMed, DOI )

  120. Yoshinouchi M, Miura M, Gaozza E, Li SW, Baserga R. Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor. Mol Endocrinol. 1993.09; 7 (9): 1161-1168. ( PubMed )

  121. Miura M, Domon M, Sasaki T, Kondo S, Takasaki Y. Restoration of proliferating cell nuclear antigen (PCNA) complex formation in xeroderma pigmentosum group A cells following cis-diamminedichloroplatinum (II)-treatment by cell fusion with normal cells. J Cell Physiol. 1992.09; 152 (3): 639-645. ( PubMed, DOI )

  122. Miura M, Domon M, Sasaki T, Kondo S, Takasaki Y. Two types of proliferating cell nuclear antigen (PCNA) complex formation in quiescent normal and xeroderma pigmentosum group A fibroblasts following ultraviolet light (uv) irradiation. Exp Cell Res. 1992.08; 201 (2): 541-544. ( PubMed )

  123. Miura M, Domon M, Sasaki T, Takasaki Y. Induction of proliferating cell nuclear antigen (PCNA) complex formation in quiescent fibroblasts from a xeroderma pigmentosum patient. J Cell Physiol. 1992.02; 150 (2): 370-376. ( PubMed, DOI )

  124. Miura M, Sasaki T. Role of glutathione in the intrinsic radioresistance of cell lines from a mouse squamous cell carcinoma. Radiat Res. 1991.05; 126 (2): 229-236. ( PubMed )

  125. Miura M, Sasaki T. Relationship between radiosensitivity and metallothionein content in clones from a mouse squamous cell carcinoma. Radiat Res. 1990.08; 123 (2): 171-175. ( PubMed )

  126. 久米　咲子，栗林　亜実，中村　伸，大山　潤，前原　健寿，菅原　貴志，三浦　雅彦. 三叉神経痛の原因となった頭蓋内類表皮嚢胞の1例 歯科放射線. 2025.04; 64 (2): 46-50.

  127. 青木隆幸、上田倫弘、山城正司、柳本惣市、寺尾保信、三浦雅彦、本間義崇、中山秀樹、八木原一博、大廣洋一、伏見千宙、林信、長島文夫、太田嘉英. 高齢者に対する口腔がん診療 日本口腔腫瘍学会誌. 2024.09; 36 (3): 53-62.

  128. 三浦雅彦. 放射線治療の生物学的基礎 日本唾液腺学会誌. 2021.11; 61 59-64.

  129. 三浦雅彦. 放射線感受性の細胞周期依存性に関する再検証の試み Isotope News. 2021.10; 777 (10月): 24-27.

  130. 遠山皓基, 加納嘉人, 野地理夏, 青柳康子, 松寺翔太郎, 大野十央, 有泉陽介, 道泰介, 富岡寛文, 島本裕彰, 吉村亮一, 朝蔭孝宏, 原田浩之, 三宅智, 三浦雅彦, 池田貞勝. 再発・転移頭頸部癌に対する網羅的がんゲノム解析と臨床的有用性 頭頚部癌. 2021.10; 47 (4): 359-366.

  131. 野地 理夏, 加納 嘉人, 平井 秀明, 山下 大和, 工藤 亮, 富岡 寛文, 島本 裕彰, 道 泰之, 大西 威一郎, 三浦 雅彦, 吉村 亮一, 三宅 智, 池田 貞勝, 原田 浩之. がんゲノム解析によりニボルマブ耐性機構が示唆された再発頰粘膜癌の一例 頭頸部癌. 2021.05; 47 (2): 182.

  132. 遠山 皓基, 加納 嘉人, 青柳 康子, 松寺 翔太郎, 大野 十央, 有泉 陽介, 富岡 寛文, 島本 裕彰, 道 泰之, 吉村 亮一, 朝蔭 孝宏, 原田 浩之, 三宅 智, 三浦 雅彦, 池田 貞勝. 再発・転移頭頸部がんに対するがんゲノムリアルワールド解析と有用性 頭頸部癌. 2020.07; 46 (2): 190.

  133. 吉村亮一, 戸田 一真, 渡邉 裕, 三浦 雅彦. 舌がんに対する小線源治療は生き残れるか？LDRの現状 頭頸部癌. 2020.07; 46 (2): 133.

  134. 島本 裕彰, 道 泰之, 横川 美咲, 奥山 紘平, 大迫 利光, 釘本 琢磨, 黒嶋 雄志, 平井 秀明, 富岡 寛文, 吉村 亮一, 三浦 雅彦, 原田 浩之. 口腔扁平上皮癌症例の臨床的検討 頭頸部癌. 2020.07; 46 (2): 170.

  135. 三浦雅彦. 放射線腫瘍学の基礎 歯科放射線. 2019.09; 59 (1): 1-7.

  136. 高草木 洋一, 松元 慎吾, 松尾 政之, 高草木 香織, 齋藤 圭太, 岸本 俊, 三浦 雅彦, 宮崎 年恭, 菅原 二三男, 坂口 謙吾, Mitchell James B., Krishna Murali C.. マルチモダル分子イメージングによる腫瘍内微小環境の多角的評価と天然由来含硫糖脂質の誘発する放射線増感作用メカニズムの解明 JSMI Report. 2019.05; 12 (2): 79. ( 医中誌 )

  137. 戒田 篤志, 三浦 雅彦 . 「細胞周期動態から考える口腔がん小線源治療の生物学的有効性」最近の歯学 口腔病学会雑誌. 2019.03; 86 (1): 6.

  138. 三浦雅彦, 戒田篤志. 放射線照射後の腫瘍細胞における再分布動態の可視化とその臨床的意義 放射線生物研究. 2018.12; 53 (4): 265-279.

  139. 三浦 雅彦, 戒田 篤志. 【顎口腔・歯科領域の画像診断と放射線治療】 口腔癌領域における放射線治療に役立つ知識　口腔癌に対する放射線治療総論 臨床画像. 2018.11; 34 (11): 1297-1302. ( 医中誌 )

  140. 三浦雅彦. [口腔がん治療における放射線治療の現状と今後] 低線量率小線源治療 日本口腔腫瘍学会誌. 2018.09; 30 (3): 123-127.

  141. 戒田 篤志, 三浦 雅彦. 【頭頸部腫瘍に対する放射線治療機器の進歩】 口腔がんに対する小線源治療の進歩 日本歯科理工学会誌. 2018.05; 37 (2): 73-76. ( 医中誌 )

  142. 三浦雅彦　他. 特集 腫瘍に対する放射線治療ー高度化・個別化治療へー 放射線の腫瘍細胞に対する作用機序 日本臨床. 2017.08; 75 (8): 1156-1159.

  143. 三浦雅彦. がん放射線治療のbiology 特集 婦人科がん放射線治療の最新知見, 産婦人科の実際. 2013; 62 (7): 889-895.

  144. 三浦雅彦. 放射線治療 放射線生物学の動向 RADIPISOTOPES. 2011.10; 60 (10): 433-442.

  145. 三浦雅彦. 唾液腺腫瘍の放射線治療 日本口腔腫瘍学会誌. 2011.09; 23 (3): 69-72.

  146. 三浦雅彦. がん治療における歯科医師の役割—口腔がんの放射線治療への関わりを中心に 放射線生物研究. 2011.09; 46 (3): 211-220.

  147. 三浦雅彦. 口腔がんの根治的放射線治療の現状と放射線増感のためのトランスレーショナル研究 東北大学歯学雑誌. 2010.12; 29 (2): 39-47.

  148. 三浦雅彦、太田慶祐、森陽子、菅原二三男、坂口謙吾. 硫酸糖脂質による血管新生阻害と放射線増感 癌の臨床. 2009.12; 55 861-864.

  149. 三浦雅彦. 放射線増感剤の基礎と新薬開発の現状 臨床放射線. 2009.07; 54 829-837.

  150. 三浦雅彦. 口腔がんに対する放射線治療とトランスレーショナルリサーチ 口腔病学会雑誌. 2009.03; 76 5-8.

  151. 阿部成宏, 三浦雅彦. 癌幹細胞に関する最近の知見とその概念に基づいた癌治療戦略 日本放射線腫瘍学会誌. 2009.03; 21 1-11.

  152. 阿部成宏, 山口聡, 濱田啓一, 天笠光雄, 三浦雅彦. 放射線による歯根形成阻害メカニズム−ヒト根末完成歯・歯尖部歯随由来細胞より単離した幹細胞様細胞の放射線生物学的検討 放射線生物研究. 2009; 44 (4): 460-471.

  153. 渋谷均, 鮎川文夫, 林敬二, 戸田一真, 三浦雅彦, 渡邊裕. 口腔, 放射線治療2.各論, 頭頸部の診断と治療update 臨床放射線. 2008; 53 1610-1620.

  154. 渡邊裕, 倉林亨, 三浦雅彦. 口腔癌小線源治療患者を対象としたマイクロアレーによる網羅的遺伝子解析 口腔病学会雑誌. 2007; 74 (1): 51.

  155. 三浦雅彦. 新規な血管新生阻害型放射線増感剤の開発 口腔病学会雑誌. 2006; 73 193.

  156. 三浦雅彦. IGF-I受容体シグナルと放射線感受性 放射線生物研究. 2006; 41 85-91.

  157. 三浦雅彦, 崎元一平, 太田慶祐, 菅原二三男, 坂口謙吾. 血管新生阻害型放射線増感剤—その開発と作用機構 放射線生物研究. 2006; 41 207-220.

  158. 三浦雅彦, 于冬. IGF-I受容体によるシグナル伝達と放射線感受性 放射線生物研究. 2005; 40 245-259.

  159. 渋谷均, 吉村亮一, 三浦雅彦, 鮎川文男, 渡邊裕. 頭頸部癌の組織内照射治療 頭頸部癌. 2005; 31 432-437.

  160. 渡邊裕, 倉林亨, 三浦雅彦. 細胞の放射線感受性におけるMEK/ERK経路活性化の意義 2004; 71 51.

  161. 渋谷均, 吉村亮一, 太田さや子, 三浦雅彦, 渡辺裕. 放射線領域別治療の実際. 口腔癌の放射線治療 2004; 20 225-229.

  162. 三浦雅彦. 口腔癌に対する放射線治療とテーラーメード医療 口腔病学会雑誌. 2004; 71 39.

  163. 渋谷均, 吉村亮一, 太田さや子, 渡辺裕, 三浦雅彦. 頭頚部扁平上皮癌の放射線治療の実際 画像診断. 2002; 22 1114-1123.

  164. 三浦雅彦. アポトーシスは常に放射線感受性を反映するか？ 癌の臨床. 2002; 48 374-376.

  165. 渋谷均, 吉村亮一, 太田さや子, 三浦雅彦. 舌癌I,II期の小線源治療とその結果 臨床放射線. 2002; 47 741-749.

  166. 三浦雅彦. 固形腫瘍の放射線照射によるアポトーシス発現頻度と放射線治療成績についての考察ーアポトーシスと放射線感受性ー 日本医学放射線学会雑誌. 2002; 62 17-20.

  167. 三浦雅彦. 電離放射線によって誘導されるDNA修復機構の多様性 口腔病学会雑誌. 2001; 68 262.

  168. 佐々木武仁, 三浦雅彦, 中村伸, 渡辺裕. ２１世紀の放射線治療を考える：感受性予測法の将来展望 癌の臨床. 2001; 47 91-94.

  169. 三浦雅彦. ノックアウトマウスリスト：細胞死:抑制因子: IGF-IR 生体の科学. 2000; 51 427.

  170. 渋谷均, 吉村亮一, 竹田正宗, 三浦雅彦. 舌癌I,II期の治療：舌癌I,II期の放射線治療適応拡大と限界 JOHNS. 2000; 16 587-591.

  171. 三浦雅彦, 渡辺裕, 大河内清, 佐々木武仁. 細胞増殖因子の発現と放射線抵抗性との関係ーI型インスリン様増殖因子レセプター遺伝子ノックアウトモデルからの考察ー 癌の臨床. 2000; 45 227-231.

  172. 三浦雅彦. ノックアウトマウスリスト：DNA修復関連タンパク(1): DNA pol β 生体の科学. 2000; 51 362.

  173. 渋谷均, 三浦雅彦, 竹田正宗, 福田穂積, 吉村亮一. 正常組織反応とその修飾ー粘膜反応（頭頸中心に） 癌の臨床. 1999; 45 255-256.

  174. 三浦雅彦. PCNAとDNA修復 放射線生物研究. 1998; 33 265-275.

  175. 三浦雅彦，Renato Baserga. 細胞増殖とトランスフォーメーションにおけるI型インスリン様増殖因子レセプター(IGF IR)の役割 影響学会通信. 1995; 6 6.

  176. 三浦雅彦，佐々木武仁. 放射線誘発DNA損傷の修復におけるPCNAの役割 医学のあゆみ. 1992; 163 835.

  177. 三浦雅彦，佐々木武仁. 腫瘍細胞の内因性放射線抵抗性に関与する内在性SH物質の役割と機構 医学のあゆみ. 1992; 160 860.

  178. 佐々木武仁，三浦雅彦. 化学療法併用放射線治療に対する期待ーシスプラチンとの併用を中心にー 癌の臨床. 1990; 36 2234-2243.

< 前のページ - 次のページ >

  • 1
このページの先頭へ▲